MEN1 and gastrin-producing neuroendocrine tumor: Consistent with its ability to repress gastrin gene expression (14), a heterozygous MEN1 variant and two heterozygous mutations were identified in all patients diagnosed with duodenal and pancreatic gastrinomas in our previously published cohort (20).